GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
GSK, Pfizer's ViiV Healthcare Shows Strong HIV Viral Suppression In Latest Study
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
LancasterOnline10d
GSK's planned $800M Lancaster County investment took state and local buy-in
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...
GlobalData on MSN12d
GSK reports positive outcomes from two Phase III trials of treatment for CRSwNP
Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.
The Mail12d
The end of an era for pharmaceutical giant
Michelle says it was “deeply disappointing” that one of her first meetings after being elected in July involved learning that the GSK site was going to close. "Over the years, all of my family have ...
BioSpace5d
FDA Action Alert: GSK, Alnylam, Sanofi and More
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.
Healio1d
Twice-yearly depemokimab for asthma tolerated well as exacerbation rates fall
Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...